Dr. Handy’s Corner: Can Adults Get a Booster Dose of Polio Vaccine If They’re Unsure about Their Immunity?
Jan 8, 2025
Watch as Dr. Handy discusses which adults might benefit from an additional dose of polio vaccine.
<p>Beckwith-Wiedemann syndrome (BWS) is a rare genetic disorder characterized by overgrowth. The syndrome occurs in 1 in 11,000 births.</p>
Jan 8, 2025
Watch as Dr. Handy discusses which adults might benefit from an additional dose of polio vaccine.
Jan 8, 2025
Unsure where to go to for trusted information about vaccines? Check out our list of resources. You'll also learn about why more information and access means more care when consuming that information.
Jan 2, 2025
In this piece, Dr. Adzick reflects on the impact the center he helped establish 30 years ago has had on the field and on families.
Jan 3, 2025
Researchers at Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania developed a new screening technology, Aptamer-based T Lymphocyte Activity Screening and SEQuencing (ATLAS-seq), to better identify antigen-reactive T cells that are more likely to offer greater immune responses against cancer cells.
Jan 13, 2025
Researchers at Children’s Hospital of Philadelphia today announced results from the first ever international survey of trochleoplasty experts, which they hope will help guide current practice and future research regarding this procedure.
Dec 20, 0024
Researchers from the Children’s Hospital of Philadelphia (CHOP) in collaboration with the School of Veterinary Medicine at the University of Pennsylvania, Perelman School of Medicine at the University of Pennsylvania and Vanderbilt University Medical Center found that venous endothelial cells (VECs), a specific type of lung blood vessel cell, can help fix damaged blood vessels in the lungs following lung injury or disease. Their findings were recently published in Nature Cardiovascular Research.
Jan 2, 2025
Researchers at Children’s Hospital of Philadelphia (CHOP) and the University of Pennsylvania Perelman School of Medicine pioneered a first of its kind gene therapy model that offers a potential breakthrough in treating X-linked sideroblastic anemia (XLSA), a rare congenital anemia caused by mutations in the ALAS2 gene crucial for the synthesis of heme, a key compound in hemoglobin. This study marks the first time researchers studied gene therapy to treat this disease, which the authors underscore could have an impact on a broad spectrum of diseases. The research was published today and featured on the cover of the journal Blood.
Dec 17, 2024
Dr. Lori Handy discusses why measles outbreaks occur and what can be done to prevent them.
Dec 12, 2024
MMFP-Tableau offers a readily generalizable solution to make research and clinical electronic health system data more accessible and impactful.
Dec 11, 2024
The 3 South Playroom in CHOP’s Main Building officially reopened after a renovation funded by generous support from Dancing While Cancering, the Maddie Kramer Foundation.